» Articles » PMID: 27136353

Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning

Overview
Journal Cell Syst
Publisher Cell Press
Date 2016 May 3
PMID 27136353
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

The structure of genetic interaction networks predicts that, analogous to synthetic lethal interactions between non-essential genes, combinations of compounds with latent activities may exhibit potent synergism. To test this hypothesis, we generated a chemical-genetic matrix of 195 diverse yeast deletion strains treated with 4,915 compounds. This approach uncovered 1,221 genotype-specific inhibitors, which we termed cryptagens. Synergism between 8,128 structurally disparate cryptagen pairs was assessed experimentally and used to benchmark predictive algorithms. A model based on the chemical-genetic matrix and the genetic interaction network failed to accurately predict synergism. However, a combined random forest and Naive Bayesian learner that associated chemical structural features with genotype-specific growth inhibition had strong predictive power. This approach identified previously unknown compound combinations that exhibited species-selective toxicity toward human fungal pathogens. This work demonstrates that machine learning methods trained on unbiased chemical-genetic interaction data may be widely applicable for the discovery of synergistic combinations in different species.

Citing Articles

Role of Artificial Intelligence in Drug Discovery to Revolutionize the Pharmaceutical Industry: Resources, Methods and Applications.

Singh P, Sachan K, Khandelwal V, Singh S, Singh S Recent Pat Biotechnol. 2025; 19(1):35-52.

PMID: 39840410 DOI: 10.2174/0118722083297406240313090140.


A Bayesian active learning platform for scalable combination drug screens.

Tosh C, Tec M, White J, Quinn J, Ibanez Sanchez G, Calder P Nat Commun. 2025; 16(1):156.

PMID: 39746987 PMC: 11696745. DOI: 10.1038/s41467-024-55287-7.


Hybrid deep learning technique for COX-2 inhibition bioactivity detection against breast cancer disease.

Pawar S, Deshmukh N, Jadhav S Biomed Eng Lett. 2024; 14(4):631-647.

PMID: 39512384 PMC: 11538098. DOI: 10.1007/s13534-024-00355-6.


Dual-view jointly learning improves personalized drug synergy prediction.

Li X, Shen B, Feng F, Li K, Tang Z, Ma L Bioinformatics. 2024; 40(10).

PMID: 39423102 PMC: 11524890. DOI: 10.1093/bioinformatics/btae604.


Transfer learning predicts species-specific drug interactions in emerging pathogens.

Chung C, Chang D, Rhoads N, Shay M, Srinivasan K, Okezue M bioRxiv. 2024; .

PMID: 38895385 PMC: 11185605. DOI: 10.1101/2024.06.04.597386.


References
1.
Strebhardt K, Ullrich A . Paul Ehrlich's magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008; 8(6):473-80. DOI: 10.1038/nrc2394. View

2.
Hartman 4th J, Garvik B, Hartwell L . Principles for the buffering of genetic variation. Science. 2001; 291(5506):1001-4. DOI: 10.1126/science.291.5506.1001. View

3.
Feala J, Cortes J, Duxbury P, Piermarocchi C, McCulloch A, Paternostro G . Systems approaches and algorithms for discovery of combinatorial therapies. Wiley Interdiscip Rev Syst Biol Med. 2010; 2(2):181-193. DOI: 10.1002/wsbm.51. View

4.
Shalem O, Sanjana N, Zhang F . High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet. 2015; 16(5):299-311. PMC: 4503232. DOI: 10.1038/nrg3899. View

5.
Robbins N, Spitzer M, Yu T, Cerone R, Averette A, Bahn Y . An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens. Cell Rep. 2015; 13(7):1481-1492. PMC: 4654976. DOI: 10.1016/j.celrep.2015.10.018. View